Department of General Internal and Psychosomatic Medicine, University Hospital Heidelberg, Heidelberg, Germany.
Department of Psychology, Klagenfurt University, Klagenfurt, Austria.
Psychooncology. 2018 Jan;27(1):83-90. doi: 10.1002/pon.4465. Epub 2017 Jul 3.
To investigate whether depressed oncology patients show a specific depressive symptom profile, we compared depression symptoms in depressed cancer patients (CANCER-DEP) and depressed patients without a chronic somatic disease (NONCANCER-DEP).
Of a total of 2493 outpatients from a comprehensive cancer center and a center for psychosocial medicine, 1054 (42.3%) met the DSM-5 criteria for depression, measured with the Patient Health Questionnaire 9. Based on the Patient Health Questionnaire 9 scores, differences in severity of each of the 9 individual DSM-5 depression symptoms between CANCER-DEP (n = 542) and NONCANCER-DEP (n = 512) were examined. Non-depressed cancer patients (CANCER-NONDEP; n = 1216) served as a comparison group for somatic symptoms independent of depression in cancer. To control for depression severity, group comparisons were performed separately for patients with major depression and any depressive disorders.
Depressed cancer patients reported significantly lower levels of the cognitive-emotional depression symptoms "worthlessness" and "suicidal thoughts" than NONCANCER-DEP. Only 1 out of 5 somatic depression symptoms ("changes in appetite") was more pronounced in CANCER-DEP than in NONCANCER-DEP. Confirming previous research, somatic depression symptoms occurred more frequently in CANCER-DEP than in CANCER-NONDEP.
The lower level of cognitive-emotional symptoms in CANCER-DEP than in NONCANCER-DEP is discussed in relation to different psychosocial phenomena. Our results indicate that somatic depression symptoms are similarly pronounced in CANCER-DEP and NONCANCER-DEP, and that CANCER-DEP show greater somatic depression symptoms than CANCER-NONDEP. The presence of high levels of somatic symptoms should alert clinicians to investigate for a potential comorbid depression in cancer patients.
为了探究抑郁的肿瘤患者是否表现出特定的抑郁症状特征,我们比较了患有癌症的抑郁患者(CANCER-DEP)和无慢性躯体疾病的抑郁患者(NONCANCER-DEP)的抑郁症状。
在综合癌症中心和心理社会医学中心的 2493 名门诊患者中,共有 1054 名(42.3%)符合 DSM-5 抑郁标准,使用患者健康问卷 9 进行测量。基于患者健康问卷 9 的得分,我们比较了 CANCER-DEP(n=542)和 NONCANCER-DEP(n=512)中 9 种 DSM-5 抑郁症状中每种症状的严重程度差异。无抑郁的癌症患者(CANCER-NONDEP;n=1216)作为癌症中独立于抑郁的躯体症状的对照组。为了控制抑郁严重程度,我们分别对患有重性抑郁障碍和任何抑郁障碍的患者进行了组间比较。
患有癌症的抑郁患者报告的认知情感抑郁症状“无价值感”和“自杀念头”的严重程度明显低于 NONCANCER-DEP。仅 5 种躯体抑郁症状中的 1 种(“食欲改变”)在 CANCER-DEP 中比在 NONCANCER-DEP 中更为突出。与之前的研究一致,躯体抑郁症状在 CANCER-DEP 中比在 CANCER-NONDEP 中更为常见。
CANCER-DEP 的认知情感症状水平低于 NONCANCER-DEP,我们讨论了与不同心理社会现象相关的原因。我们的结果表明,躯体抑郁症状在 CANCER-DEP 和 NONCANCER-DEP 中同样明显,并且 CANCER-DEP 的躯体抑郁症状比 CANCER-NONDEP 更严重。高水平的躯体症状的存在应该提醒临床医生在癌症患者中调查是否存在潜在的共患抑郁。